Talk:Intention-to-treat analysis

Discussion page·2 threads·no archives

This is the discussion page for the article Intention-to-treat analysis. It is for improving the article: sources, wording, structure, scope and titles. It is not a general discussion forum about the subject, and it is not a place to ask for advice — see Project:Medical disclaimer.

Adherence in the placebo armResolved

The placebo-adherence finding is the single most convincing argument against per-protocol analysis and belongs in the article rather than only in the reading list. — ITT_Imelda (talk) 09:35, 24 January 2026 (UTC)

Added with the explanation of why it happens — adherence as a marker for other behaviour. ✓ Done — ForestPlotFinn (talk) 13:10, 24 January 2026 (UTC)

Resolved. This thread is closed. Reopening it is fine if new sources appear; please add a new subsection rather than editing the closed discussion.

Which estimand a source usedDone

This explains why the same trial is quoted with different weight-loss figures in different places. Worth linking from the trial articles. — DataTableDunja (talk) 10:20, 27 April 2026 (UTC)

Linked from STEP and SURMOUNT. ✓ Done — CrossRefCleve (talk) 13:55, 27 April 2026 (UTC)

Done. This thread is closed. Reopening it is fine if new sources appear; please add a new subsection rather than editing the closed discussion.

This page was last edited on 27 April 2026, by CrossRefCleve. Text is available under the PeptidePedia Wiki Content Licence (PPCL-BY-SA 4.0).